Page last updated: 2024-08-25

magnolol and hematoxylin

magnolol has been researched along with hematoxylin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gu, M; Guo, W; Huang, L; Liu, Y; Sun, H; Wang, N; Wu, Y; Xu, L; Yang, Y1

Other Studies

1 other study(ies) available for magnolol and hematoxylin

ArticleYear
Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury.
    International immunopharmacology, 2022, Volume: 112

    Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Eosine Yellowish-(YS); Glaucoma; Hematoxylin; Inflammation; Ischemia; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; PPAR gamma; Reperfusion Injury; Retina

2022